Rimasys, a Cologne, Germany-based medtech startup, received a funding round from High-Tech Gründerfonds.
The company intends to use the funds to expand the fracture portfolio, upgrade production technology and increase international reach.
Founded in January 2016 as an independent university spin-off from the Institute of Biomechanics & Orthopaedics of the German Sports University Cologne, Rimasys developed an algorithm and device to generate life-like fractures in human specimen.
The fractured specimen have been piloted with international MedTech companies and hospital chains enhancing their educational offering for surgeons and supporting the development of new implants – first formal roll-out is scheduled for the upcoming year.
The fracture portfolio covers all medical relevant traumata of the upper and lower limb. Further expansion is planned into hip, spine, and CMF. Revenues are generated with top international MedTech companies and hospital chains. Future developments target medical societies, health insurers, and areas of injury simulation, virtual reality, and 3D-printing.
The company started internationalization this year with orders from Germany, Switzerland, and Australia with plans to expand into North America and Asia in 2018.